Post show results
In 2022, 269 companies from 23 countries were represented at the Pharmtech & Ingredients Exposition, including 80 companies participating in the Exposition for the first time. Manufacturers and suppliers from Russia, Germany, Italy, India, Vietnam, China, Brazil, Belarus, Switzerland, the Czech Republic, and other countries presented their latest products at their booths. Companies from China, Turkey, and the UAE have intensified their operations showing great interest in the Russian pharmaceutical market this year.
Pharmtech & Ingredients 2022 Exposition generated keen interest among pharmaceutical industry experts. The exposition participants noted high demand for equipment, raw materials, and technologies that were presented at the booths. A total of 7,982 unique industry experts attended the exposition (4,888 visitors in 2021, 2,811 in 2020, 8,231 in 2019, 8,069 in 2018) from 64 regions of Russia (60 in 2021, 57 in 2020, 57 in 2019) and 26 countries of the world, including representatives of all EAEU countries (Belarus, Armenia, Kyrgyzstan, Kazakhstan). Taking into account repeated visits, a total of 9,488 experts attended the exposition. The final visit rate was 32 guests per participant (19 in 2021, 16 in 2020, 22 in 2019).
The qualitative composition of 2022 Exposition visitors remains consistently high. The share of key visitors was 76% or 6,066 experts (3,764 (77%) in 2021, 2,080 (74%) in 2020, 5,926 (72%) in 2019), including more than 3,200 (40%) guests visiting the exhibition in search for products and services for their business purposes (2,004 (41%) in 2021, 1,068 (38%) in 2020, 2,963 (36%) in 2019). The share of decision makers was 68% or 5,428 experts (3,421 (70%) in 2021, 1,883 (67%) in 2020, 5,185 (63%) in 2019). Over 3,250 visitors represented companies with procurement budgets from RUB 20 mln to more than RUB 50 mln. Their share has increased by 41% as compared to previous years (1,955 (40%) in 2021, 1,011 (36%) in 2020 and 2,963 (2019)).
The exposition was attended by representatives of the largest pharmaceutical manufacturing companies: Bayer, Stada, Sotex, Akrikhin, Biocad, Berlin Pharma, Biotech, Binnopharm Group, Valenta Pharm, Veropharm, Generium, Geropharm, Gedeon Richter-Rus, Scientific Production Association Microgen, Nanolek, Scientific Production Association Petrovax Pharm, Scientific and Technological Pharmaceutical Company, Polysan, R Pharm, Synthesis, SkopinFarm, Tathimpharm Preparations, Pharmasynthesis, Pharmstandard, Evalar and others.
